Longboard Pharmaceuticals, Inc.
USD59.98
CEO
Kevin R. Lind
IPO Date
2021-03-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Day Low
$59.98
Day High
$59.98
52W Low
$59.98
52W High
$59.98
Market Cap
$2.34B
| 14 Oct 2024 |
| Cantor Fitzgerald |
| Overweight |
| Neutral |
| downgrade |
| 18 Sept 2024 | HC Wainwright & Co. | Buy | Buy | maintain |
| 17 Sept 2024 | Wedbush | Outperform | Outperform | maintain |
| 16 Sept 2024 | Cantor Fitzgerald | Overweight | Overweight | maintain |
| 26 Aug 2024 | Evercore ISI Group | Outperform | Outperform | maintain |
| 22 Aug 2024 | HC Wainwright & Co. | Buy | Buy | maintain |
| 5 Aug 2024 | B. Riley Securities | Buy | Buy | maintain |